The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening
This paper was published in CiteSeerX.
Having an issue?
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.